Oswal Pumps IPO: Price band set at ₹584-614 per share; check issue details, key dates, more

Oswal Pumps IPO price band: The Oswal Pumps Limited IPO price band has been fixed in the range of ₹ 584 to ₹ 614 per equity share of the face value of Re 1. The Oswal Pumps IPO date of subscription is scheduled for Friday, June 13, and will close on Tuesday, June 17. The allocation to anchor investors for the Oswal Pumps IPO is scheduled to take place on Thursday, June 12.
The floor price is 584 times the face value of the equity shares and the cap price is 614 times the face value of the equity shares. Oswal Pumps IPO lot size is 24 equity shares and in multiples of 24 equity shares thereafter.
Oswal Pumps IPO has reserved not more than 50% of the shares in the public issue for qualified institutional buyers (QIB), not less than 15% for non-institutional Institutional Investors (NII), and not less than 35% of the offer is reserved for retail investors.
Tentatively, Oswal Pumps IPO basis of allotment of shares will be finalised on Wednesday, June 18, and the company will initiate refunds on Thursday, June 19, while the shares will be credited to the demat account of allottees on the same day following refund. Oswal Pumps share price is likely to be listed on BSE and NSE on Friday, June 20.
The firm focuses on producing solar-powered and grid-connected submersible and monoblock pumps, electric motors including induction and submersible types, as well as solar modules, all marketed under the 'Oswal' brand. With over 22 years in the industry, it has accumulated significant knowledge in engineering, product design, manufacturing, and testing.
As of December 31, 2024, Oswal Pumps had fulfilled 38,132 turnkey solar pumping system orders under the PM Kusum Scheme in states such as Haryana, Rajasthan, Uttar Pradesh, and Maharashtra.
According to the red herring prospectus (RHP), the company's publicly listed competitors include Kirloskar Brothers Ltd (with a P/E of 41.94), Shakti Pumps (India) Ltd (with a P/E of 66.72), WPIL Ltd (with a P/E of 27.31), KSB Ltd (with a P/E of 66.79), and Roto Pumps Ltd (with a P/E of 42.08).
For the nine months ending December 2024, the company disclosed revenues of ₹ 1,065.67 crore and a net profit of ₹ 216.71 crore. As of April 2025, the total outstanding borrowings on a standalone basis were ₹ 308.57 crore.
The IPO includes a new issuance of equity shares worth ₹ 890 crore and a sale of up to 8.1 million shares by one of the company's promoters, Vivek Gupta, who currently holds a 25.17 percent stake in the firm.
Of the funds raised, ₹ 89.86 crore will be used for capital expenditures, ₹ 273 crore will be invested in the subsidiary Oswal Solar to build a new manufacturing facility in Haryana, ₹ 280 crore will be dedicated to debt repayment, and ₹ 31 crore will go towards settling debt at Oswal Solar.
The leading managers for this issue are IIFL Capital, Axis Capital, CLSA India, JM Financial, and Nuvama Wealth Management.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Standard

30 minutes ago

• Business Standard

Influx Healthtech IPO booked 200x; check allotment, GMP, listing date

Influx Healthtech IPO allotment status: The basis of allotment of shares for Influx Healthtech is expected to be finalised today, Monday, June 23, 2025. The initial public offering (IPO) of Influx Healthtech, which closed for subscription on Friday, June 20, received a robust response from investors, with the offering being over subscribed by over 201 times. Investors bid for 817.53 million equity shares, which was 201.4 times the public issue size of 4.05 million shares, through 220,338 applications. After the allotment process is completed, investors can verify their IPO allotment status by visiting the official websites of the National Stock Exchange (NSE) and Maashitla Securities, the designated registrar for the Influx Healthtech IPO. Alternatively, they can use the direct links provided below to check their allotment status online: Check Influx Healthtech IPO allotment status on NSE: Check Influx Healthtech IPO allotment status on Maashitla Securities: Influx Healthtech IPO grey market premium (GMP) The unlisted shares of Influx Healthtech were trading at ₹118 in the grey market, commanding a premium of ₹22 or 22.3 per cent compared to the upper price band of ₹96 per share, according to sources tracking unofficial markets. Influx Healthtech IPO details The Mumbai-based company aims to raise ₹58.57 crore through a combination of a fresh issue of 5 million equity shares and an offer for sale (OFS) of 1.1 million equity shares at a price band of ₹91-96 per share. Shares of Influx Healthtech are scheduled to be listed on the NSE SME platform on Wednesday, June 25. Rarever Financial Advisors is the sole book-running lead manager. According to the red herring prospectus (RHP), the company intends to use the net fresh issue proceeds for the set up of the manufacturing facility Nutraceutical Division, a manufacturing facility for the Veterinary Food Division; purchase of machinery for Homecare and Cosmetic Division, and general corporate purposes. About Influx Healthtech Incorporated in 2020, Mumbai-based Influx Healthtech is a healthcare-focused company specialising in contract manufacturing. It operates a manufacturing facility located in Thane, Maharashtra. The company produces Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, care products, Active Pharmaceutical Ingredients (APIs), and finished dosage forms, including tablets, capsules, and injectables.

Business Standard

30 minutes ago

• Business Standard

Vedanta, 2 others to trade ex-dividend on June 24; do you own any?

Dividend stocks: Shares of Vedanta, Polycab India, and Alkyl Amines Chemicals are set to remain in spotlight today, June 23, following their announcement of dividend rewards for their shareholders. These shares, BSE data suggest, will trade ex-dividend tomorrow, June 24. The ex-dividend date is when a stock starts trading without the right to receive the declared dividend. To be eligible, investors must own the stock before this date. Companies determine the list of eligible shareholders based on their records on the record date. Vedanta dividend 2025 Metal and mining major Vedanta informed the exchanges that its board of directors has considered and approved the first interim dividend of ₹7 per equity share on face value of ₹1 per equity share for the Financial Year 2025-26, amounting to ₹2,737 crore. The record date for the purpose of payment of dividend, Vedanta said, shall be Tuesday, June 24, 2025, and the interim dividend shall be duly paid within the stipulated timelines as prescribed under law. Polycab India dividend 2025 Wires and cables manufacturer Polycab India 's board has recommended a dividend @ 350 per cent i.e. ₹35 per equity share of face value of ₹10 each for the Financial Year 2024-25, subject to approval of members at the ensuing Annual General Meeting. "The dividend, if approved by the members in the ensuing Annual General Meeting, will be paid on or before 30 days from the date of the Annual General Meeting," said the company in an exchange filing. Alkyl Amines Chemicals dividend 2025 Specialty chemicals manufacturer Alkyl Amines Chemicals has informed the exchanges that its board has recommended a final dividend of ₹10 per equity share of ₹2 each (i.e., 500 per cent) for the Financial Year (F.Y.) 2024-25. The dividend is, however, subject to approval by the shareholders at the ensuing Annual General Meeting. Alkyl Amines Chemicals has fixed Tuesday, June 24, 2025, as the 'record date' for determining entitlement of members to dividend for the financial year ended March 31, 2025, if approved at the AGM.

Business Standard

31 minutes ago

• Business Standard

Arisinfra Solutions IPO allotment today; check status, GMP, listing date

Arisinfra Solutions IPO allotment status: The basis of allotment for the Arisinfra Solutions IPO shares is likely to be finalised today, Monday, June 23, 2025. The public offering closed for subscription on Friday, June 20, 2025, receiving decent participation from investors and getting oversubscribed by 2.65 times. Here's how to check Arisinfra Solutions IPO online Once the Arisinfra Solutions IPO allotment is finalised, investors can check their status on the official websites of BSE, NSE, or MUFG Intime India (erstwhile Link Intime), the registrar for the issue. Alternatively, investors can use these direct links to check the Arisinfra Solutions IPO allotment status directly: Arisinfra Solutions IPO final subscription status The ₹499.60 crore public offering of Arisinfra Solutions, offered at a price band of ₹210–222 with a lot size of 67 shares, received bids for 3,46,72,835 shares against the 1,30,84,656 shares offered. This led to an oversubscription of 2.65 times by the end of the subscription period, according to data available on the BSE. Arisinfra Solutions IPO witnessed the highest participation from the retail investors who subscribed to 5.59 times the portion reserved for them, non-institutional investors (NIIs) at 3.14 times, and qualified institutional buyers (QIBs) at 1.42 times. Arisinfra Solutions IPO grey market premium (GMP) today According to sources tracking unofficial market activities, the unlisted shares of Arisinfra Solutions were seen trading flat at ₹222 per share. Thus, the grey market premium (GMP) for Arisinfra Solutions IPO remains nil on Monday. Arisinfra Solutions IPO likely listing price Shares of Arisinfra Solutions are scheduled to list on the BSE and NSE on Wednesday, June 25, 2025. The current grey market trends indicate a flat listing of Arisinfra Solutions shares. However, these estimates may vary, as the grey market is unregulated, and GMP should not be considered a reliable indicator of performance. About Arisinfra Solutions Incorporated in 2021, Arisinfra Solutions is a B2B technology-driven platform that simplifies procurement processes for construction and infrastructure companies. The company delivers a range of construction materials, including steel, cement, and aggregates. The company's product portfolio includes GI pipes, MS wire, and OPC bulk cement. Arisinfra Solutions has a subsidiary, ArisUnitern Re Solutions Private, which provides value-added services to real estate developers.